Abstract
The implanted cardioverter-defibrillator (ICD) is frequently used in the management of high-risk patients with long QT syndrome (LQTS). The following factors indicate a high risk for aborted cardiac arrest or death: corrected QT interval prolongation, history of aborted cardiac arrest (ACA), history of syncope, and information on mutations. History of ACA or syncope despite β-blocker treatment is an approved ICD indication in patients with LQTS. Programming of ICDs requires further investigation because there is no uniform protocol to decrease the risk of therapies delivered when self-terminating episodes of torsade de pointes ventricular tachycardia might occur.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
